Childhood-Onset Hereditary Spastic Paraplegia (HSP): A Case Series and Review of Literature

Tanya F Panwala1, Rocio Garcia-Santibanez2, Joaquin A Vizcarra2

  • 1Florida Atlantic University, Charles E. Schmidt College of Medicine, Boca Raton, Florida.

Pediatric Neurology
|March 18, 2022
PubMed

Insights

Childhood-onset hereditary spastic paraplegia (HSP) often presents with neurocognitive deficits and polyneuropathy. Whole-exome sequencing is crucial for diagnosing rare genetic causes of HSP.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Hereditary spastic paraplegia (HSP) is a group of rare genetic disorders affecting the corticospinal tract, leading to progressive lower limb spasticity and weakness.
  • Published data on genetically confirmed pediatric HSP cases are limited, highlighting a need for further research.

Purpose of the Study:

  • To review clinical characteristics, genetic etiologies, and comorbidities in a cohort of pediatric patients with hereditary spastic paraplegia.
  • To evaluate the diagnostic utility of advanced genetic testing in childhood-onset HSP.

Main Methods:

  • Retrospective review of 16 patients with childhood-onset HSP treated at Children's and Emory Healthcare.
  • Data collected included clinical presentation, family history, neurological examination, electrodiagnostics, neuroimaging, genetic testing, comorbidities, and treatment outcomes.

Main Results:

  • The cohort included 16 patients (8 male, 8 female) with a mean age of 19 years. Gait difficulty was the primary presenting symptom in 66% of patients.
  • Genetic etiologies were confirmed in 16 patients, including SPAST, MARS, KIF1A, and others. Average time from symptom onset to genetic confirmation was 8.2 years.
  • Comorbidities included sensory motor axonal polyneuropathy (44%), developmental delay (56%), autism (31%), epilepsy (19%), and ADHD (13%).

Conclusions:

  • Childhood-onset HSP frequently involves neurocognitive deficits, polyneuropathy, and rare genetic causes.
  • Whole-exome sequencing and genetic neuropathy panels are effective tools for establishing HSP diagnoses in pediatric patients.
Abstract